NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tesamorelin from Reta-Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+19 more ↓
50%
Finnrick rating
#48 of 114 Tesamorelin vendors
9 of 19 classifiable tests passed
natural 47% · customers 4.4★ (10)
methodology · Purity focus
Finnrick analysis · Tesamorelin

Reta-Peptide Tesamorelin has a mixed evidence profile: many 2025 results fell below 99.5% purity, while recent COAs improved. The -33% fill result passed this wide-fill method but shows quantity volatility.

methodology →
vendor intelligence report
Vendor Intelligence Report: Reta-Peptide

Echemi records, RDAP, and archived policies point to a China-centered trading operation behind a U.S.-listed brand, with the legal counterparty still unresolved. The report maps Reta-Peptide to Retalux, Peptaura batch tokens, lookalike domains, and direct-payment gaps.

38 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
94%
28
2
Retatrutide
$1.00
85%
90
3
Tirzepatide
$0.47
85%
39
4
Ipamorelin
$0.72
77%
17
5
PT-141
$0.60
72%
6
6
SS-31
$0.66
70%
6
7
Semaglutide
$0.50
70%
2
8
Melanotan II
$0.40
63%
5
9
Cagrilintide
$1.35
58%
4
10
BPC-157
$0.78
53%
21
11
Tesamorelinselected
$2.48
50%
19
12
MOTS-c
$0.57
40%
10
13
TB-500
$1.50
38%
13
14
CJC-1295
-
32%
9
15
NAD+
$0.01
30%
4
16
5-Amino-1MQ
$1.40
-
0
17
GLOW
$0.31
-
0
18
hCG
$0.00
-
0
19
HGH
$0.54
-
0
20
Kisspeptin
$0.99
-
0
21
KLOW
-
-
0
22
KPV
$0.75
-
0
23
LL-37
$1.52
-
0
25
SLU-PP-332
$2.40
-
0
27
Wolverine
$1.26
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%9 Sep 2025: 19%9 Sep 2025: 18%13 Sep 2025: 21%9 Oct 2025: 22%23 Oct 2025: 26%23 Oct 2025: 25%17 Nov 2025: 22%17 Nov 2025: 21%25 Nov 2025: 18%2 Mar 2026: 31%12 Mar 2026: 31%18 Mar 2026: 34%27 Apr 2026: 38%20 May 2026: 42%28 May 2026: 44%4 Jun 2026: 47%15 Jun 2026: 49%20 Jul 2026: 47%12 Oct 2026: 50%15 Nov 2026: current 50%19%31%50%Sep 25Nov 26
Showing Tesamorelin tests only
Peptide testing

Ordered Tesamorelin from Reta-Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Reta-Peptide Tesamorelin test history
COA-backed lab tests
1-10 of 19

About Reta-Peptide test results from Finnrick

Reta-Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 273 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Reta-Peptide peptides in this dataset are BPC-157 (21 tests), Cagrilintide (4 tests) and CJC-1295 (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests. It also includes 1 correction related to this vendor.

Corrections
2025-09-26
Customer update
Batch identifier provided after publishing. Test score updated from 7.3 to 9.3.
Peptide testing

Ordered Tesamorelin from Reta-Peptide? Mail in a sample (US only) and let us test it.

Test my supply